Weight Trajectory Impacts Risk for 10 Distinct Cardiometabolic Diseases
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Context: Repetitive bouts of weight loss and regain, termed weight cycling, may exaggerate the risk for cardiometabolic disease. We previously identified that weight cyclers were likely to have prescribed medications for hypertension, dyslipidemia, and diabetes—suggesting a high prevalence of cardiometabolic disease. Objective: No prior study has compared relationships between longitudinal weight trajectory (weight stable, weight gainer, weight loser, or weight cycler) and commonly occurring specific cardiometabolic diseases among persons with similar high baseline body mass index (BMI). Methods: Using de-identified electronic health record data from all adults treated at Vanderbilt University Medical Center between 1997 to 2020 and a landmark approach, we developed multivariate Cox proportional hazards regression models to determine relationships between weight trajectory and risk for 10 highly prevalent cardiometabolic diseases. Results: Compared to weight stability, weight cycling associated with an almost 30% increased risk for obstructive sleep apnea [hazard ratio (HR) 1.28; 95% confidence interval (CI) 1.15-1.42], metabolic dysfunction-associated steatotic liver disease (HR 1.28; 95% CI 1.08-1.51), and type 2 diabetes (HR 1.23; 95% CI 1.10-1.38). Weight cycling also associated with a more than 50% increased risk for heart failure (HR 1.54; 95% CI 1.31-1.82), although both weight gain and weight loss also showed increased risk for heart failure (HR 1.29; 95% CI 1.08-1.55 and HR 1.32; 95% CI 1.10-1.58, respectively). Conclusion: The relationship between weight cycling and cardiometabolic disease risk was independent of having high baseline BMI, which was similar among weight trajectory groups. The present findings support promoting either weight stability at high BMI or weight loss if able to be maintained to prevent the incidence of a variety of cardiometabolic diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“has been associated with adverse cardiometabolic outcomes”
From Weight maintenance after discontinuation of GLP-1 therapies (2026) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.06.003 · Cited by 3,100
Longitudinal Study of Moderate Weight Change and Sleep-Disordered Breathing
Peppard, P. E. (2000) · JAMA · doi:10.1001/jama.284.23.3015 · Cited by 2,020
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Polyzos, S. A., Kountouras, J., & Mantzoros, C. S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.014 · Cited by 1,211
Lean, M. E. J., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30068-3 · Cited by 1,017
Weight Loss and Improvement in Comorbidity: Differences at 5%, 10%, 15%, and Over
Ryan, D. H., & Yockey, S. R. (2017) · Current Obesity Reports · doi:10.1007/s13679-017-0262-y · Cited by 831
Landmark Analysis at the 25-Year Landmark Point
Dafni, U. (2011) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.957951 · Cited by 569
MedEx: a medication information extraction system for clinical narratives
Xu, H., Stenner, S. P., Doan, S., Johnson, K. B., Waitman, L. R., & Denny, J. C. (2010) · Journal of the American Medical Informatics Association · doi:10.1197/jamia.m3378 · Cited by 531
Obesity and the risk of cardiometabolic diseases
Valenzuela, P. L., Carrera-Bastos, P., Castillo-García, A., Lieberman, D. E., Santos-Lozano, A., & Lucia, A. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00847-5 · Cited by 452 · cited 1×
“25,26 Determining the influence of each weight trajectory type for specific cardiovascular diseases would inform health care providers as well as advance weight management practices in the current highly obesogenic environment.”
Pathophysiology of heart failure
Schwinger, R. H. G. (2021) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-20-302 · Cited by 428
Fildes, A., Charlton, J., Rudisill, C., Littlejohns, P., Prevost, A. T., & Gulliford, M. C. (2015) · American Journal of Public Health · doi:10.2105/ajph.2015.302773 · Cited by 394
Research works printed but not linked: 2
- Jensen MD, Ryan DH, Apovian CM, et al 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the obesity society. Circulation. 2014; 129(25 Suppl 2): S102‐ S138. 24222017 PMC5819889
- Pacheco J, Thompson W. Type 2 Diabetes Mellitus. Northwestern University PheKB; 2012.
Cited by
Weight maintenance after discontinuation of GLP-1 therapies
Moiz, A., Filion, K. B., Knäuper, B., Tsoukas, M. A., Brazeau, A.-S., Zolotarova, T., Lelièvre, A., & Eisenberg, M. J. (2026) · EClinicalMedicine · doi:10.1016/j.eclinm.2026.103992 · Cited by 7
Wiebe, N., & Tonelli, M. A. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-092962 · Cited by 6
Iizuka, K., Matsuura, H., Yanagi, K., Hiraiwa, E., Sato, Y., Kaito, K., Yamamoto-Wada, R., Deguchi, K., & Naruse, H. (2026) · Nutrients · doi:10.3390/nu18071156 · Cited by 4
“Both weight cycling and sustained weight gain were reported to be associated with higher risks compared to stable weight cycling [34].”
Khan, S. S., Grobman, W. A., Perak, A. M., Angell, S. Y., Brubaker, L. T., Cameron, N. A., Ferranti, S., Khoudary, S. R. E., Ferranti, E. P., Hameed, A. B., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001483 · Cited by 4
Wiebe, N., Thompson, S., Stenvinkel, P., Bello, A. K., James, M. T., & Tonelli, M. A. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70568 · Cited by 1
Challenges in mitigating weight regain with incretin-based therapy
Scheen, A. J. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00871-8 · Cited by 1
Guss, S. (2026) · Journal of Consumer Health on the Internet · doi:10.1080/15398285.2026.2618934
“This includes shifting standards of care away from encouraging weight loss at all, based on increasing evidence that intentional weight loss doesn’t work and is often harmful (Fildes et al. 2015; Gaesser and Angadi 2021; Swartz et al. 2025).”
Hennessy, C., Swartz, A. Z., Harrell, F. E., & Silver, H. J. (2026) · BMC Medical Research Methodology · doi:10.1186/s12874-026-02881-6
“[7 , 8].”
Self-citationAdipose macrophage heterogeneity: A potential immunometabolic target for preventing weight regain
Li, M., Hua, Z. X., Ban, C.-L., & Li, Q. Y. (2026) · Med · doi:10.1016/j.medj.2026.101188
Oforka, O. K., LaVoy, E. C. P., Cottam, M. A., Kapadia, M., Nguyen, E., Hegemann, C., Hasty, A. H., Winn, N. C., & Caslin, H. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.25.740730 · Cited by 1
“Importantly, weight cycling worsens the risk of many cardiometabolic diseases even more than obesity itself 7,8 .”
Teng, F., Li, S., & Liu, D. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1867835
Gordofobia y obesidad: todo mal. La influencia del sesgo en la concepción del cuerpo gordo
Amat, M. S. (2026) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2026.03.004
Metadata
- Authors
- Swartz, A. Z., Wood, K., Farber-Eger, E., Petty, A., & Silver, H. J.
- Affiliations
- Vanderbilt University (US)
- Vanderbilt University Medical Center (US)
- Department of Pharmacology, Vanderbilt University Medical Center , Nashville, TN 37232 ,
- VA Tennessee Valley Healthcare System (US)
- Corresponding author
- Silver, Heidi J
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2025-06-11
- Volume
- 111
- Issue
- 1
- Pages
- e49-e57
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC12712981
- OpenAlex
- W4411202560
- Cited by
- 10
- References
- 45
- Citations by year
- 2026: 9 · 2025: 1
- FWCI
- 9.11
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Funders
- CTSA (UL1TR002243)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity and Health Practices
- Keywords
- weight cycling, weight trajectories, cardiometabolic disease, obesity, obstructive sleep apnea, non-alcoholic fatty liver disease, type 2 diabetes, heart failure, weight loss, weight gain, body mass index, disease risk
- MeSH terms
- Body-Weight Trajectory, Cardiometabolic Risk Factors, Adult, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Male, Metabolic Diseases, Middle Aged, Risk Factors, Weight Gain, Weight Loss, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.



